Article
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal
1 Jan 2003
Abstract excerpt
Recent progress in the development of molecular cancer therapeutics has revealed new types of antitumor drugs, such as Herceptin, Gleevec, and Iressa, as potent therapeutics for specific tumors. Our work has focused on molecular cancer therapeutics, mainly in the areas of drug resistance, apoptosis and apoptosis resistance, and survival-signaling, which is related to drug resistance. In this review, we describe...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
